HealthPhoto: Hindu BusinessZydus Receives US FDA Approval for Hormone Therapy Patch Generic
Zydus has obtained approval from the US FDA for its generic version of a hormone therapy patch. The product qualifies for a 180-day exclusivity period under the CGT pathway, according to the US Federal Food, Drug, and Cosmetic Act provisions. This exclusivity applies to certain first approved applicants.
Hindu Business·




